1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Small-Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Small-Cell Lung Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Small-Cell Lung Cancer 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials 35
Prominent Drugs 36
Latest Clinical Trials News on Small-Cell Lung Cancer 37
May 28, 2015: OncoMed Pharmaceuticals to Review Key ASCO Data for Tarextumab During Conference Call on Tuesday, June 2, 2015 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
GlaxoSmithKline Plc 38
Clinical Trial Overview of GlaxoSmithKline Plc 38
Eli Lilly and Company 40
Clinical Trial Overview of Eli Lilly and Company 40
Novartis AG 42
Clinical Trial Overview of Novartis AG 42
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
AstraZeneca Plc 46
Clinical Trial Overview of AstraZeneca Plc 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Celgene Corporation 49
Clinical Trial Overview of Celgene Corporation 49
F. Hoffmann-La Roche Ltd. 50
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 50
Bayer AG 51
Clinical Trial Overview of Bayer AG 51
Clinical Trial Overview of Top Institutes / Government 52
National Cancer Institute 52
Clinical Trial Overview of National Cancer Institute 52
European Organization for Research and Treatment of Cancer 62
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 62
Sarah Cannon Research Institute 63
Clinical Trial Overview of Sarah Cannon Research Institute 63
Case Comprehensive Cancer Center 65
Clinical Trial Overview of Case Comprehensive Cancer Center 65
Hoosier Cancer Research Network 66
Clinical Trial Overview of Hoosier Cancer Research Network 66
Maastricht Radiation Oncology 67
Clinical Trial Overview of Maastricht Radiation Oncology 67
Medical Research Council 68
Clinical Trial Overview of Medical Research Council 68
Japan Clinical Oncology Group 69
Clinical Trial Overview of Japan Clinical Oncology Group 69
National Cancer Center 70
Clinical Trial Overview of National Cancer Center 70
NCIC Clinical Trials Group 71
Clinical Trial Overview of NCIC Clinical Trials Group 71
Five Key Clinical Profiles 72
Appendix 118
Abbreviations 118
Definitions 118
Research Methodology 119
Secondary Research 119
About GlobalData 120
Contact Us 120
Disclaimer 120
Source 121

List of Tables
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Small-Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Small-Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Small-Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 32
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 33
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 34
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 35
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 36
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 38
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 40
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 42
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 44
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 46
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 47
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 48
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 49
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 50
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 51
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 52
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 62
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2015* 63
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 65
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoosier Cancer Research Network, 2015* 66
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht Radiation Oncology, 2015* 67
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2015* 68
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Clinical Oncology Group, 2015* 69
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015* 70
Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2015* 71

List of Figures
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 32
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 33
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 34
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 35
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 36
GlobalData Methodology 119

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

Related Market Segments :

Therapy
Cancer
Clinical Trial
Chemotherapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.